William Duke - Apexigen Chief Officer
| APGNDelisted Stock | USD 0.43 0.01 2.27% |
Insider
William Duke is Chief Officer of Apexigen
| Age | 51 |
| Phone | 650-931-6236 |
| Web | https://www.apexigen.com |
William Duke Latest Insider Activity
Tracking and analyzing the buying and selling activities of William Duke against Apexigen stock is an integral part of due diligence when investing in Apexigen. William Duke insider activity provides valuable insight into whether Apexigen is net buyers or sellers over its current business cycle. Note, Apexigen insiders must abide by specific rules, including filing SEC forms every time they buy or sell Apexigen'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
William Duke over a year ago Payment of 4504 shares by William Duke of Apexigen subject to Rule 16b-3 |
Apexigen Management Efficiency
The company has return on total asset (ROA) of (0.894) % which means that it has lost $0.894 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (15.9805) %, meaning that it created substantial loss on money invested by shareholders. Apexigen's management efficiency ratios could be used to measure how well Apexigen manages its routine affairs as well as how well it operates its assets and liabilities.Apexigen currently holds 106 K in liabilities with Debt to Equity (D/E) ratio of 0.05, which may suggest the company is not taking enough advantage from borrowing. Apexigen has a current ratio of 1.22, suggesting that it is in a questionable position to pay out its financial obligations when due. Note, when we think about Apexigen's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Arthur Taveras | X4 Pharmaceuticals | 60 | |
| Peter Facchini | Enveric Biosciences | 60 | |
| MBA MD | Immix Biopharma | 49 | |
| Cynthia Sirard | Leap Therapeutics | 54 | |
| Gabriel BA | Immix Biopharma | 37 | |
| Avani Kanubaddi | Enveric Biosciences | 51 | |
| DSc MSE | Immix Biopharma | 75 | |
| Walter Newman | Leap Therapeutics | 78 | |
| Christine Granfield | Leap Therapeutics | 56 | |
| Mary DiBiase | X4 Pharmaceuticals | 63 | |
| Dr MedSc | Phio Pharmaceuticals Corp | 68 | |
| Richard MD | X4 Pharmaceuticals | 61 | |
| JD MBA | Immix Biopharma | N/A | |
| Ibrahim MD | Enveric Biosciences | 55 | |
| Augustine Lawlor | Leap Therapeutics | 67 | |
| Renato Skerlj | X4 Pharmaceuticals | N/A | |
| Joseph Tucker | Enveric Biosciences | 55 | |
| Nandan BS | Immix Biopharma | 62 | |
| Keith MD | X4 Pharmaceuticals | 53 | |
| Murray MD | X4 Pharmaceuticals | 63 | |
| Mark OMahony | Leap Therapeutics | 53 | |
Management Performance
| Return On Equity | -15.98 | |||
| Return On Asset | -0.89 |
Apexigen Leadership Team
Elected by the shareholders, the Apexigen's board of directors comprises two types of representatives: Apexigen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Apexigen. The board's role is to monitor Apexigen's management team and ensure that shareholders' interests are well served. Apexigen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Apexigen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Xiaodong MD, CEO Pres | ||
| Francis Sarena, Chief Officer | ||
| Frank MD, Chief Officer | ||
| William Duke, Chief Officer | ||
| Jason Wright, VP CMC | ||
| Amy Wong, Sr Operations |
Apexigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Apexigen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -15.98 | |||
| Return On Asset | -0.89 | |||
| Current Valuation | 205.33 K | |||
| Shares Outstanding | 24.86 M | |||
| Shares Owned By Insiders | 8.81 % | |||
| Shares Owned By Institutions | 13.54 % | |||
| Number Of Shares Shorted | 64.45 K | |||
| Price To Book | 2.32 X | |||
| EBITDA | (32.58 M) | |||
| Net Income | (32.07 M) |
Pair Trading with Apexigen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Apexigen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apexigen will appreciate offsetting losses from the drop in the long position's value.Moving against Apexigen Stock
The ability to find closely correlated positions to Apexigen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Apexigen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Apexigen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Apexigen to buy it.
The correlation of Apexigen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Apexigen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Apexigen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Apexigen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Apexigen Stock
If you are still planning to invest in Apexigen check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Apexigen's history and understand the potential risks before investing.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |